beta-lactams has been researched along with glutamic acid in 10 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 41,757 | 452 | 12,876 |
| Protein | Taxonomy | beta-lactams (IC50) | glutamic acid (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
| Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Herzberg, O | 1 |
| Cleveland, DW; Miller, TM | 1 |
| Secko, D | 1 |
| Amin, M; Rawls, SM; Robinson, W; Tallarida, R | 1 |
| Nielsen, J; Noorman, H; Rueksomtawin, K; Thykaer, J | 1 |
| Abrahams, KA; Breukink, E; Philippe, J; Roper, DI; Signor, L; Vernet, T; Zapun, A | 1 |
| Biswal, S; Ghosh, AS; Issa, B; Kar, D; Kumar, G | 1 |
| Biswal, S; Ghosh, AS; Kumar, G; Nathan, S | 1 |
| Abou-Gharbia, M; Alhaddad, H; Bell, RL; Childers, W; Melenski, E; Sari, Y; Wong, W | 1 |
| Al-Trad, B; Amawi, H; Hall, FS; Hammad, AM; Naser, A; Tiwari, AK | 1 |
10 other study(ies) available for beta-lactams and glutamic acid
| Article | Year |
|---|---|
Relocation of the catalytic carboxylate group in class A beta-lactamase: the structure and function of the mutant enzyme Glu166-->Gln:Asn170-->Asp.
Topics: Acylation; Anti-Bacterial Agents; Asparagine; Aspartic Acid; beta-Lactamases; beta-Lactams; Catalytic Domain; Crystallography, X-Ray; Glutamic Acid; Glutamine; Kinetics; Models, Molecular; Mutation; Protein Conformation; Staphylococcus aureus; Structure-Activity Relationship | 1999 |
Medicine. Treating neurodegenerative diseases with antibiotics.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; beta-Lactams; Brain; Ceftriaxone; Clinical Trials as Topic; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Mice; Motor Neurons; Neurodegenerative Diseases; Spinal Cord; Synapses; Synaptic Transmission | 2005 |
Antibiotics that protect the brain.
Topics: Amino Acid Transport System X-AG; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Mice; Neuroprotective Agents; Promoter Regions, Genetic; RNA, Messenger | 2005 |
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Anti-Bacterial Agents; Aspartic Acid; beta-Lactams; Body Temperature; Ceftriaxone; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Rats; Rats, Sprague-Dawley; Riluzole; Time Factors | 2007 |
NADPH-dependent glutamate dehydrogenase in Penicillium chrysogenum is involved in regulation of beta-lactam production.
Topics: Anti-Bacterial Agents; beta-Lactams; Biomass; Fungal Proteins; Gene Deletion; Glutamate Dehydrogenase (NADP+); Glutamic Acid; Metabolic Networks and Pathways; Models, Biological; Mutagenesis, Insertional; Penicillium chrysogenum; Proline; Quaternary Ammonium Compounds | 2008 |
In vitro reconstitution of peptidoglycan assembly from the Gram-positive pathogen Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cell Wall; Genetic Engineering; Glutamic Acid; Glutamine; Homologous Recombination; Penicillin-Binding Proteins; Peptidoglycan; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Streptococcus pneumoniae; Uridine Diphosphate N-Acetylmuramic Acid | 2013 |
E152A substitution drastically affects NDM-5 activity.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glutamic Acid; Hydrolysis; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mutation | 2017 |
Glutamate residues at positions 162 and 164 influence the beta-lactamase activity of SHV-14 obtained from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Catalytic Domain; Drug Resistance, Bacterial; Escherichia coli; Glutamic Acid; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation | 2018 |
Effects of a Novel Beta Lactam Compound, MC-100093, on the Expression of Glutamate Transporters/Receptors and Ethanol Drinking Behavior of Alcohol-Preferring Rats.
Topics: Alcohol Drinking; Animals; beta-Lactams; Ethanol; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Nucleus Accumbens; Peroxisome Proliferator-Activated Receptors; Rats | 2022 |
Effect of amoxicillin/clavulanic acid in attenuating pregabalin-induced condition place preference.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Excitatory Amino Acid Transporter 2; Glutamates; Glutamic Acid; Humans; Nucleus Accumbens; Pregabalin; Substance-Related Disorders | 2023 |